Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000421311 | SCV000536117 | uncertain significance | not provided | 2017-01-13 | criteria provided, single submitter | clinical testing | The c.509+5A>C variant in the SYNGAP1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to damage the natural splice donor site in intron 5, which may cause abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. The c.509+5A>C variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.509+5A>C as a variant of uncertain significance. |
Invitae | RCV000689210 | SCV000816850 | likely benign | Intellectual disability, autosomal dominant 5 | 2023-08-04 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000689210 | SCV003818864 | uncertain significance | Intellectual disability, autosomal dominant 5 | 2019-10-02 | criteria provided, single submitter | clinical testing |